我要投票 翔宇医疗XIANGYU在医疗器械行业中的票数:670
· 外 推 电 报 ·
2026-01-09 08:15:51 星期五

【翔宇医疗XIANGYU是哪个国家的品牌?】

翔宇医疗XIANGYU是什么牌子?「翔宇医疗XIANGYU」是安阳市翔宇医疗设备有限责任公司旗下著名品牌。该品牌发源于河南省安阳市,由创始人郭 * 玲在2002年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力翔宇医疗XIANGYU品牌出海!将品牌入驻外推网,定制翔宇医疗XIANGYU品牌推广信息,可以显著提高翔宇医疗XIANGYU产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

翔宇医疗(XIANGYU MEDICAL)成立于2002年,注册资金6200万元,是一家专注于康复理疗设备和创伤治疗设备的研发、生产、销售为一体的企业,生产基地位于中国内黄县产业集聚区。截止2017年4月底,公司拥有员工800余人,产品注册证48个。

主要产品涵盖:声疗、光疗、电疗、磁疗、冷疗、热疗、蜡疗、汽疗、音乐疗法、压力疗法、按摩疗法、牵引疗法、PT运动疗法、OT作业疗法、ST语言疗法、康复评测产品及进口康复产品,共有产品700多种型号,所有产品均为卫计委康复中心建设要求配置的品种;产品遍布全国各级医疗单位,并已出口到欧洲、非洲、澳洲、中东及东南亚等国家。与德国、美国、韩国、意大利、英国等多个国家的康复设备生产企业建立战略合作关系。

翔宇医疗竭诚为全国残联系统、民政系统提供一、二、三级康复中心(医院)建设方案、疼痛治疗中心提供整体解决方案、专项解决方案、单个设备和设备组合的规划设计方案及技术支持。翔宇医疗为方案实施提供所在区域市场调研和SWOT分析的学科发展定位,并以此提供专业科室规划服务、人才培养计划、科室管理保障、信息化网络技术等支持。

截止2016年11月,市场覆盖全国31个省市,渠道合作伙伴10000余家,市场覆盖率达到40%以上,直接服务10万余家医疗机构,为数亿患者解决康复问题。

2012年翔宇医疗投资6亿元,占地面积500余亩,12万平方标准化车间。专注打造国内较大的康复理疗设备制造中心和全国较大的中医诊疗设备生产示范基地之一。2017年公司计划打造国际健康城,健康城一期项目工程计划投资30亿元,项目包含:三级甲等康复医院、养老中心、国际会议中心、康复医学博物馆、康复设备展览馆、康复技术研究院等标志性工程。


英文翻译:Xiangyu medical, founded in 2002 with a registered capital of 62 million yuan, is an enterprise focusing on the R & D, production and sales of rehabilitation physical therapy equipment and trauma treatment equipment. Its production base is located in the industrial cluster of Neihuang County, China. By the end of April 2017, the company has more than 800 employees and 48 product registration certificates. The main products include: acoustic therapy, phototherapy, electrotherapy, magnetic therapy, cold therapy, hyperthermia, wax therapy, steam therapy, music therapy, pressure therapy, massage therapy, traction therapy, Pt sports therapy, OT operation therapy, St language therapy, rehabilitation evaluation products and imported rehabilitation products. There are more than 700 types of products, all of which are required by the construction of the rehabilitation center of the health and Family Planning Commission Products all over the country at all levels of medical units, and has been exported to Europe, Africa, Australia, the Middle East and Southeast Asia and other countries. Establish strategic cooperation with rehabilitation equipment manufacturers in Germany, the United States, South Korea, Italy, the United Kingdom and other countries. Xiangyu medical wholeheartedly provides the first, second and third level Rehabilitation Center (hospital) construction scheme, pain treatment center with overall solution, special solution, planning and design scheme and technical support of single equipment and equipment combination for the national disabled persons' Federation system and civil affairs system. Xiangyu medical provides the discipline development orientation of regional market research and SWOT analysis for the implementation of the plan, and provides professional department planning services, personnel training plan, department management guarantee, information network technology and other support. As of November 2016, the market has covered 31 provinces and cities nationwide, more than 10000 channel partners, with a market coverage rate of more than 40%, directly serving more than 100000 medical institutions, and solving rehabilitation problems for hundreds of millions of patients. In 2012, Xiangyu medical investment reached 600 million yuan, covering an area of more than 500 mu and 120000 square meters of standardized workshops. Focus on building a large rehabilitation physiotherapy equipment manufacturing center in China and one of the large production demonstration bases of TCM diagnosis and treatment equipment in China. In 2017, the company plans to build an international health city. The first phase of the project is planned to invest 3 billion yuan. The project includes three class a rehabilitation hospitals, pension centers, international conference centers, rehabilitation medicine museums, rehabilitation equipment exhibition halls, rehabilitation technology research institutes and other landmark projects.

本文链接: https://www.waitui.com/brand/b84b5c08f.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

华纳兄弟探索公司拒绝派拉蒙,坚持与Netflix的交易

华纳兄弟探索公司敦促股东拒绝派拉蒙的敌意收购,并重申其将工作室和流媒体资产出售给Netflix的协议是更优报价,且完成路径更明确。(新浪财经)

16分钟前

Grok因涉性图像面临审查

埃隆·马斯克麾下未上市企业xAI在其Grok模型被用于生成涉性图像(包括未成年人图像)后受到抨击,这引发了监管机构对该与X平台集成的工具的调查和政策质疑。(新浪财经)

16分钟前

保险公司发债规模连续三年超千亿元,多重因素推动

连续三年,保险公司发行债券规模超千亿元。刚刚过去的2025年,23家保险公司发债规模合计达1042亿元。业内人士普遍认为,这背后有多重推动因素——低利率周期下,保险公司普遍面临较高的资本补充需求;利率下行,发债成本更低,险企有动力发新债置换旧债;也有险企希望在利率低位时融资以进一步夯实资本实力、增厚发展安全垫。另外,在逆周期监管思路下,保险公司发债也在一定程度上获得了监管部门的支持。(证券时报)

16分钟前

中信建投:白酒板块迎来周期底部配置机会

36氪获悉,中信建投指出,白酒产业“五底阶段”(政策底、库存底、动销底、批价底、产销底)与资本市场“三低一高”(预期低、估值低、公募持仓低、高分红)共振,结合近期市场策略相继落地,站在春节旺季来临之际,认为本轮白酒调整期拐点将至,资本市场预期先行,白酒板块迎来周期底部配置机会。

16分钟前

CrowdStrike以7.4亿美元收购身份安全初创公司SGNL

网络安全提供商CrowdStrike周四宣布,将以近7.4亿美元的价格收购身份管理初创公司SGNL,以在人工智能网络攻击时代加强防御。该公司表示,此次收购将帮助CrowdStrike的Falcon云安全平台用户更好地管理人员和人工智能身份访问请求以及实时风险。该交易预计将于2027财年第一季度完成。(新浪财经)

16分钟前

本页详细列出关于翔宇医疗XIANGYU的品牌信息,含品牌所属公司介绍,翔宇医疗XIANGYU所处行业的品牌地位及优势。
咨询